Long-Term Efficacy of Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization in a Case of Fundus Flavimaculatus (FFM).

Authors	Ioanna Zygoula, Lars Hefner, Heinrich Gerding
Journal	Klinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 239 Issue 4 Pg. 531-533 (04 2022) ISSN: 1439-3999 [Electronic] Germany
Vernacular Title	Langzeitige Effektivität der intravitrealen Anti-VEGF-Injektionstherapie chorioidaler Neovaskularisationen bei einem Patienten mit Fundus flavimaculatus (FFM).
PMID	35472799 (Publication Type: Case Reports, Journal Article)
Chemical References	Angiogenesis Inhibitors Antibodies, Monoclonal Ranibizumab
Topics	Angiogenesis Inhibitors (therapeutic use) Antibodies, Monoclonal (therapeutic use) Choroidal Neovascularization (drug therapy) Humans Ranibizumab (therapeutic use) Stargardt Disease

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!